https://pubmed.ncbi.nlm.nih.gov/38091578
This study found that using a T-reg graft plus single-agent tacrolimus is preferred over T-reg graft alone for preventing acute graft-versus-host disease (GVHD) in allogeneic hematopoietic cell transplantation, although it results in a higher incidence of moderate to severe chronic GVHD.